ArticleNeuro-oncology practice2024

Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.

Britt A E Dhaenens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.